Home 禄 Metro 禄 Health and Science
Children's drug linked to deaths withdrawn by stores
LOCAL pharmacies have stopped selling Nimesulide Granules, a children's anti-inflammatory drug manufactured by Hainan-based Honz Pharmaceutical, after it was linked to several deaths.
One outlet said it received notice from its headquarters to remove the product, according to a local TV news report yesterday. "We have arranged to return the drug to its manufacturers," a worker at the pharmacy said.
Shanghai Kaixinren Drug Store has also told its outlets to remove other anti-fever drugs containing nimesulide ingredients, China Business News reported.
Nimesulide Granules - which also goes by the name Ruizhiqing - and is used for treating fever in children, is reported to have caused adverse reactions and even death.
China Central Television's news channel reported last November that Nimesulide Granules harmed the nervous system and liver, citing China's National Center for Adverse Reaction Monitoring.
The report said the drug has led to several deaths and several thousand cases of adverse reactions since it was launched nine years ago. Media reports in the past few days dubbed it a "life-taking" fever tablet.
"These reports are groundless and the production procedure of Ruizhiqing meets national standards and is safe," Honz said in a statement.
Ruizhiqing makes up of more than 80 percent of the company's sales.
One outlet said it received notice from its headquarters to remove the product, according to a local TV news report yesterday. "We have arranged to return the drug to its manufacturers," a worker at the pharmacy said.
Shanghai Kaixinren Drug Store has also told its outlets to remove other anti-fever drugs containing nimesulide ingredients, China Business News reported.
Nimesulide Granules - which also goes by the name Ruizhiqing - and is used for treating fever in children, is reported to have caused adverse reactions and even death.
China Central Television's news channel reported last November that Nimesulide Granules harmed the nervous system and liver, citing China's National Center for Adverse Reaction Monitoring.
The report said the drug has led to several deaths and several thousand cases of adverse reactions since it was launched nine years ago. Media reports in the past few days dubbed it a "life-taking" fever tablet.
"These reports are groundless and the production procedure of Ruizhiqing meets national standards and is safe," Honz said in a statement.
Ruizhiqing makes up of more than 80 percent of the company's sales.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔$粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.